Avi Goldberg

At Activ Surgical, our mission is for every surgical imaging system to deliver intelligent information that reduces surgical complication rates, ushering in a new standard of patient care and safety. Having completed the world’s first autonomous robotic surgery of soft tissue in 2018, the company is focused on enhanced, real-time visualization capabilities for surgeons that combine advanced augmented reality (AR), artificial intelligence (AI), and machine learning (ML) technology. Our vision is to transform the collective surgical experience by leveraging emerging technologies and data into insights that make world-class surgery accessible for all.

Datalogz is the BI Ops platform that provides visibility into BI environments. With it, we enable organizations to instantly cut costs, reduce risks, and increase BI efficiency. We work with data mature organizations with the goal of reducing and eliminating BI sprawl. We’re a fast-growing, culture-focused, venture-backed startup dedicated to building products that re-imagine an organizations Business Intelligence environment. As a team, we practice what we preach: we work hard to cultivate an environment in which people feel comfortable bringing their full selves to work every day.

Our mission is to provide unprecedented access to blood testing. We enable sustainable healthcare with accessible blood testing for a healthier you.

Commercial real estate financing, reimagined.

Assembly is on a mission to make urban development more scalable and sustainable. Novel technology, enabling aerospace levels of precision, allows us to design and deliver high-rise buildings quickly, at less cost, and more efficiently than ever before. Assembly buildings are custom, imaginative, green, and peerless in quality—all while creating market-driven affordability, enabling diverse participation in building delivery, and bringing design excellence to more and more communities.

Zafgen (Nasdaq:ZFGN) is a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients affected by a range of complex metabolic diseases. The company has pioneered the study of MetAP2 inhibitors in both common and rare metabolic disorders, and its current disease areas of focus are type 2 diabetes, Prader-Willi syndrome and other rare and serious forms of obesity. Zafgen is well-capitalized and has assembled a team accomplished in bringing therapies to patients affected by metabolic disease.

At Activ Surgical, our mission is for every surgical imaging system to deliver intelligent information that reduces surgical complication rates, ushering in a new standard of patient care and safety. Having completed the world’s first autonomous robotic surgery of soft tissue in 2018, the company is focused on enhanced, real-time visualization capabilities for surgeons that combine advanced augmented reality (AR), artificial intelligence (AI), and machine learning (ML) technology. Our vision is to transform the collective surgical experience by leveraging emerging technologies and data into insights that make world-class surgery accessible for all.

Datalogz is the BI Ops platform that provides visibility into BI environments. With it, we enable organizations to instantly cut costs, reduce risks, and increase BI efficiency. We work with data mature organizations with the goal of reducing and eliminating BI sprawl. We’re a fast-growing, culture-focused, venture-backed startup dedicated to building products that re-imagine an organizations Business Intelligence environment. As a team, we practice what we preach: we work hard to cultivate an environment in which people feel comfortable bringing their full selves to work every day.

Our mission is to provide unprecedented access to blood testing. We enable sustainable healthcare with accessible blood testing for a healthier you.

GreatPoint Ventures is an early-stage venture capital firm founded by entrepreneurs and operators whove built companies cumulatively worth $300 billion. We invest between $250k and $20m into Seed, A, and B rounds, most often leading Series As. Our mission is to partner with entrepreneurs solving big problems across enterprise, healthcare, bio-tech, and food. At GPV we make fewer than 10 new investments per year so we have time to fight in the trenches with every team we back.

Efficiency is a lost art. We help companies from startups to Fortune-500s design and implement high-ROI technology solutions to achieve immediate, tangible effects on their top or bottom lines.